Malwa-Med Iwona Chlebicka
- Address
- Antoniego Słonimskiego 25, 50-304, Wroclaw, Poland
Malwa-Med Iwona Chlebicka - Immunology and Rheumatology Research Center
Malwa-Med Iwona Chlebicka is a specialized clinical research facility dedicated to advancing treatment options for immune-mediated inflammatory conditions. The center focuses on evaluating novel therapeutic approaches for patients with chronic inflammatory diseases affecting both musculoskeletal and dermatological systems, with particular emphasis on conditions that significantly impact quality of life and require systemic intervention.
- Axial spondyloarthritis and early inflammatory spinal diseases
- Atopic dermatitis and severe hand eczema requiring systemic therapy
- JAK inhibitors and biologic therapies for inflammatory conditions
The research center demonstrates expertise in conducting randomized, placebo-controlled trials evaluating both small molecule inhibitors and biologic agents. Their clinical trial portfolio includes investigation of tofacitinib for early axial spondyloarthritis patients with inadequate NSAID response, as well as tralokinumab monotherapy for patients with moderate-to-severe atopic hand eczema. This dual focus on rheumatological and dermatological inflammatory conditions positions the center at the forefront of immune-mediated disease research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Malwa-Med Iwona Chlebicka
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase 3b, interventional, adaptive, clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate-to-severe atopic hand eczema who are candidates for systemic therapy (ADHAND) | Leo Pharma A/S | Phase I | Not Recruiting | May 2024 | Sep 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Naproxen | 1 | Unknown | 2023-11-16 | 2023-11-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.